Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):209-16. doi: 10.1016/j.pnpbp.2007.07.030. Epub 2007 Aug 19.

Abstract

Serotonin transporter (5-HTT) activity is greater in carriers of the long (L) vs. short (S) alleles of the 5-HTT-linked polymorphic region (5'-HTTLPR) among healthy control subjects but not alcohol-dependent adults. In 198 alcoholics, we determined the relationship between current or lifetime drinking and platelet 5-HTT function and density among allelic variants of the 5'-HTTLPR. SS subjects were younger than L-carriers (LL and LS) (p<0.0085) and had fewer years of lifetime drinking. For L-carriers, the mean of Bmax for paroxetine binding, but not Vmax for serotonin (5-HT) uptake, was lower than that for SS subjects (p<0.05). More L-carriers than their SS counterparts had Vmax for 5-HT uptake below 200 nmol/10(7) platelets-min (p<0.05) and Bmax for paroxetine binding below 600 nmol/mg protein (p<0.06). Current drinking (drinks per day during the past 14 days) correlated positively with Km and Vmax of platelet 5-HT uptake (p<0.05) and negatively with Bmax, but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Years of lifetime drinking correlated negatively with Km and Vmax of platelet 5-HT uptake (p<0.05) and B(max), but not Kd, of paroxetine binding (p<0.05) for L-carriers alone. Among L-carriers alone, there were higher levels of platelet 5-HT uptake and lower levels of platelet paroxetine binding with increased drinking, and more lifetime drinking was associated with modestly lower levels of 5-HT uptake and paroxetine binding. Thus, 5-HTT expression varies with current and lifetime drinking in L-carriers alone.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alcoholism / blood*
  • Alcoholism / genetics*
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Paroxetine / pharmacokinetics
  • Polymorphism, Genetic / genetics
  • Predictive Value of Tests
  • Regression Analysis
  • Retrospective Studies
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Serotonin / blood*
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Severity of Illness Index
  • Statistics as Topic

Substances

  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Serotonin
  • Paroxetine